kinlytic

Frequently asked questions

What does Kinlytic treat?

Kinlytic (Urokinase) may be used to treat coronary thrombosis, vascular graft occlusion, myocardial infarction, pulmonary embolism, venous thrombosis, based on NIH RxClass drug-classification data (conditions a drug may treat — not a verbatim copy of the FDA-approved label). This is general reference, not medical advice.

Is there a coupon or discount for Kinlytic?

pharmaranks is an independent ratings site, not a pharmacy — we don't issue coupons or sell Kinlytic. To pay less, ask your prescriber or pharmacist whether a generic equivalent exists, check the manufacturer's copay/savings card and patient-assistance program, and compare a pharmacy discount card against your insurance copay. Prices vary by pharmacy, insurance, and location, so always confirm at the counter. This is general reference, not medical or financial advice.

Who makes Kinlytic?

Kinlytic is marketed by Microbix Biosystems. You can see Microbix Biosystems's full profile, rating, and other products on pharmaranks.

Is Kinlytic a brand-name or generic drug?

Kinlytic is a brand-name product with the active ingredient Urokinase.

Is Kinlytic available over the counter?

No. Kinlytic is a prescription (Rx) medication in the US — you need a prescription from a licensed clinician (in person or via telehealth); it isn't sold over the counter. For some conditions there are OTC alternatives — ask your pharmacist.

What forms does Kinlytic come in?

Kinlytic is currently marketed as injectable, per the FDA's National Drug Code Directory.

Is Kinlytic FDA-registered?

Kinlytic is on record with the U.S. FDA under application number BLA021846. You can verify this on its official FDA label.